drugset / Trial / NCT05921968
Effect of Lactoferrin Versus Intravenous Iron Sucrose in Treatment of Anemia
RandomizedParallel-groupOpen-labelTreatment
Summary
Iron deficiency is the most common nutritional deficiency and the most common cause of anemia. Anemia has a significant impact on the health of the fetus as well as that of the mother. It impairs the oxygen delivery through the placenta to the fetus and interferes with the normal intrauterine growth, leading to fetal loss and perinatal deaths. Anemia is associated with increased preterm labor (28.2%), preeclampsia (31.2%), and maternal sepsis. The study aims to compare the effect of Lactoferrin versus intravenous iron sucrose for the treatment of iron deficiency anemia during pregnancy.
Timeline
- Start
- 2023-07-30
- Primary completion
- 2024-01-01
- Completion
- 2024-04-01
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Iron sucrose | Unknown | 200 mg | Intravenous |
| Comparator | Lactoferrin | Protein / enzyme biologic | 100 mg | Oral |